IFN-α enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells

International Immunology

Volumn 14, Issue 4, 2002, Pages 367-380

  Luft, Thomas ^b   Luetjens, Petra ^c   Hochrein, Hubertus ^a   Toy, Tracey ^a   Masterman, Kelly Anne ^a   Rizkalla, Mark ^a   Maliszewski, Charlie ^d   Shortman, Ken ^a   Cebon, Jonathan ^a   Maraskovsky, Eugene ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d AMGEN INC   (United States)

Author keywords

Cellular activation; Cellular differentiation; Cytokines; Dendritic cells; Human

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; B7 ANTIGEN; CD40 LIGAND; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR7; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PEPTIDE; PROTEIN P35; PROTEIN P40;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STIMULUS RESPONSE;

EID: 0036201905     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/14.4.367     Document Type: Article

References (71)

1. Immune defence in mice lacking type I and/ or type II interferon receptors
2. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses
3. Type I interferons are essential mediators of apoptotic death in virally infected cells
4. Autoimmune events during interferon beta-1b treatment for multiple sclerosis
5. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a
6. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha
7. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alpha therapy in chronic hepatitis C
8. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
9. + T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice
10. IFN-alpha-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs
11. Type I IFN enhance the terminal differentiation of dendritic cells
12. Natural adjuvants: Endogenous activators of dendritic cells
13. Type I Interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
14. Differential regulation of human blood dendritic cell subsets by IFN
15. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon
16. The nature of the principal type 1 interferon-producing cells in human blood
17. Natural interferon alpha/beta-producing cells link innate and adaptive immunity
18. Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries?
19. Dendritic cells and the control of immunity
20. Activation of STAT4 by IL-12 and IFN-alpha: Evidence for the involvement of ligand-induced tyrosine and serine phosphorylation
21. T helper differentiation proceeds through Stat1-dependent, Stat4- dependent and Stat4-independent phases
22. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
23. h cell development by type I IFN
24. Interferon-alpha activates multiple STAT proteins and up-regulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells
25. Analysis of the antagonist effect of IFN-alpha on IFN-gamma-induced interferon consensus sequence binding protein messenger RNA in murine macrophages
26. Modulation of interferon consensus sequence binding protein mRNA in murine peritoneal macrophages. Induction by IFN-gamma and down-regulation by IFN-alpha, dexamethasone, and protein kinase inhibitors
27. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias
28. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development
29. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection
30. IFN-alpha priming of human monocytes differentially regulates Gram-positive and Gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression
31. h1 cell development
32. IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: Selective inhibition of CD40-dependent interleukin-12 secretion
33. High-level IL-12 production by human dendritic cells requires two signals
34. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: Synergistic activation of interleukin 12 production
35. IL-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells
36. h2 phenotype by dendritic cells
37. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4
38. IL-1β enhances CD40L-mediated cytokine secretion by human dendritic cells (DC): A mechanism for T cell independent DC activation
39. IL-1b induces dendritic cells to produce IL-12
40. Studies of Endocytosis
41. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
42. In vivo production and function of IL-12 p40 homodimers
43. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
44. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: Intracellular storage and kinetics of presentation
45. h cells
46. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells
47. Cytokine expression by human peripheral blood dendritic cells stimulated in vitro with HIV-1 and herpes simplex virus
48. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha
49. Production of interferon-alpha/beta by murine dendritic cell lines stimulated by virus and bacteria
50. The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses
51. Constitutive and virus-induced interferon production by peripheral blood leukocytes
52. Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-alpha/beta producers in mice upon intravenous challenge with herpes simplex virus
53. CSF-1-induced resistance to viral infection in murine macrophages
54. Interferon produced endogenously in response to CSF-1 augments the functional differentiation of progeny macrophages
55. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice
56. Analysis of the interrelationship between IL-12, TNF-alpha, and IFN-gamma production during murine listeriosis
57. Acquired resistance but not innate resistance to Mycobacterium bovis bacillus Calmette-Guérin is compromised by interleukin-12 ablation
58. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection
59. Interleukin-12 and tumor necrosis factor alpha mediate innate production of gamma interferon by group B Streptococcus-treated splenocytes of severe combined immunodeficiency mice
60. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
61. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
62. Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment
63. Interleukin-1 beta in coronary arteries of patients wit ischemic heart disease
64. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor
65. Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells
66. Proliferation and extracellular matrix production by human infragenicular smooth muscle cells in response to interleukin-1 beta
67. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
68. Role of viruses in the loss of tolerance to self-antigens and in autoimmune diseases
69. Possible mechanisms in the pathogenesis of virus-induced diabetes mellitus
70. The pathogenesis of postinfectious myocarditis
71. Viral induction of autoimmunity: Mechanisms and examples in hepatology